$0.47
+0.08 (+20.74%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where BIAF is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional · 3 observational · 1 with posted results
Held by 2 tracked-famous managers (SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC) · FINRA short interest 1.5 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.NCT07168993Evaluate FlowPath Lung Test Detection of Early-Stage Lung Cancer in SputumOpen-label · Diagnostic | Not applicable | Recruiting | Other: Standard medical treatment, Standard medical treatment | Lung Cancer (Diagnosis) | 2,063 | 2029-04-01 | in 956 d | 2026-07-16 |
| Collection of Sputum and Labeling for Lung CancerNCT03457415observationalIdentification of Differential Characteristics | — | Recruiting | — | Lung Cancer | 500 | Dec 2025 | — | 2025-04-01 |
| Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung AssayNCT05870592observationalPrimary Objective | — | Unknown status | — | Lung Cancer | 40 | Mar 2024 | — | 2023-07-11 |
| Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung CancerNCT03837600observationalAssay Optimization | — | Completed | — | Lung Cancer | 197 | 2018-08-15actual | — | 2023-07-27 |
| Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung CancerNCT02388074results2015-06-17Number of Red Fluorescent [i.e., Cancer] Cells (RFCs) in Sputum From Healthy ParticipantsSingle-masked · Diagnostic | Not applicable | Completed | Device: CyPath® | Lung Cancer | 25 | Apr 2015actual | — | 2015-07-14 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19